About The Cleveland Cord Blood Center
The Cleveland Cord Blood Center (CCBC) is an independent, public cord blood bank. Since its founding in 2008, the not-for- profit 501(c)(3) collects, processes, stores and distributes stem-cell rich umbilical cord blood for transplantation in patients with life threatening disorders such as leukemia, lymphoma and immune system disorders. The Cleveland Cord Blood Center was founded by Mary J. Laughlin, M.D., who performed one of the world’s first successful umbilical cord blood stem cell transplants on an adult leukemia patient in 1995.
FDA Approval for CLEVECORD™
On September 1, 2016, the CCBC received a biologics license from the U.S. Food and Drug Administration (FDA) for CLEVECORD, a stem cell product derived from umbilical cord blood for use in stem cell transplants. The FDA approval of CLEVECORD reflects the organization's ability to meet the highest quality standards in the industry for distribution of cord blood products to transplant centers throughout the U.S. and around the world.
Hospital Collection Sites
In Cleveland -- Hillcrest Hospital and Fairview Hospital
In Atlanta - Emory Midtown Hospital and Piedmont Atlanta Hospital
Up to 50 percent of parents giving birth in CCBC’s partner hospitals donate their baby's umbilical cord blood, a rate well above the national average.
Serving a Diverse Population's Unmet Need
The Cleveland Cord Blood Center's diverse donor pool in Atlanta and Cleveland helps ensure good matches for patients of African American, Latino and Asian decent for whom well-matched stem cell grafts are not generally available in the adult donor registry.
Located at the Global Cardiovascular Innovation Center in Cleveland, CCBC scientists are conducting innovative research in the development of stem cell treatments to address unmet medical needs in patients suffering from Parkinson’s Disease, diabetes, HIV/AIDS and those with wound healing issues.